USPTO serial 99180527
OOCUITY
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- MATZINGER, AMY L
- Law office
- TMO LAW OFFICE 127
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OOCUITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arturo Perez Guerrero
Arturo Perez GuerreroP.O. Box 9024163San Juan, PR 00902-4163United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for medical use for the treatment of psychiatric diseases and disorders; Pharmaceutical preparation for the diagnosis and treatment of brain diseases and disorders; Pharmaceutical preparation for medical use for the treatment of Parkinson's disease, Alzheimer's disease, epilepsy and all types of neurological and neuropsychiatric disorders and diseases; Pharmaceutical preparation for medical use for the treatment of symptoms of Parkinson's disease, symptoms of Alzheimer's disease, symptoms of epilepsy and symptoms linked to all types of neurological and neuropsychiatric disorders and diseases; Pharmaceutical preparation for the diagnosis and treatment of neurological disorders and diseases for use with deep brain stimulation, transcranial electrical stimulation, transcranial direct current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation including light, magnetic field, electric field, radio frequency or ultrasound stimulation; Nanoparticles for medical use, namely, nanomaterial-based chemical preparations for medical and pharmaceutical purpose for the treatment of central nervous system disorder; Chemical reagents for medical use; Chemical preparations for medical or pharmaceutical use , namely, for the treatment of central nervous system disorders; Diagnostic preparations for medical purposes; Medicines for human medicine, namely, medical preparations for the treatment of central nervous system disorders; Pharmaceutical products for the treatment of central nervous system disorders | ACTIVE | — |
| 010 | Surgical devices and instruments, in particular for the diagnosis and treatment of tumors; Surgical apparatus and instruments, in particular for the diagnosis and treatment of cerebral diseases and disorders; Surgical devices and instruments for use with deep brain stimulation, transcranial electrical stimulation, transcranial direct current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation including light, magnetic field, electric field, radiofrequency or ultrasound stimulation; Drug delivery agents in the form of dissolvable films that facilitate the delivery of therapeutic and diagnostic agents; medical microsyringes that facilitate the delivery of therapeutic and diagnostic agents; Medical device for recording cerebral electrical activity, namely, electrodes, electroencephalograph, microelectrode arrays | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design services, in the field of nanomedicine, namely, nanotechnology applied to medicine; Biological research; Design and development of new products for third parties; Chemical analysis; Research in the field of chemistry; Neuroscience research; Radiobiology research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 5, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 5, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 5, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 5, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |